- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Diabetes cases soar in the UK
17 August 2015 • Author: Victoria White
The number of people living with diabetes in the UK has soared by nearly 60% in a decade, according to a new analysis by Diabetes UK.
The new figures show that there are now 3,333,069 people diagnosed with diabetes, which is an increase of more than 1.2 million adults compared with ten years ago.
Diabetes UK is warning that this exponential growth in numbers reflects an urgent need for effective care for people living with diabetes, as well as highlighting the importance of prevention and that failure to act on this threatens to bring down the NHS.
At present only six in ten people with diabetes in England and Wales receive the eight care processes recommended by the National Institute for Health Care and Excellence (NICE). These are the checks identified as essential in high quality care for people with diabetes and include getting blood pressure and blood glucose levels measured, as well as the kidney function monitored, otherwise poorly managed diabetes can lead to devastating and expensive health complications such as kidney disease, stroke and amputation.
Diabetes UK has said that it is critical that the UK government takes urgent action to ensure that everyone with diabetes receives the eight care processes, reducing their risk of further health complications and the costs these incur for the already strained NHS budget.
Diabetes costs the NHS nearly £10 billion a year
Barbara Young, Chief Executive of Diabetes UK, said, “Over the past decade, the number of people living with diabetes in the UK has increased by over 1 million people, which is the equivalent of the population of a small country such as Cyprus. With a record number of people now living with diabetes in the UK, there is no time to waste – the government must act now.
“We need to see more people with diabetes receiving the eight care processes recommended by NICE. It is unacceptable that a third of people living with the condition do not currently get these, putting them at increased risk of developing complications, such as amputations, heart attack or stroke.
“Diabetes already costs the NHS nearly £10 billion a year, and 80% of this is spent on managing avoidable complications. So there is huge potential to save money and reduce pressure on NHS hospitals and services through providing better care to prevent people with diabetes from developing devastating and costly complications.
“The NHS must prioritise providing better care, along with improved and more flexible education options, for people with diabetes now, and give them the best possible chance of living long and healthy lives. Until then, avoidable human suffering will continue and the costs of treating diabetes will continue to spiral out of control and threaten to bankrupt the NHS. Now is the time for action.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics